BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marasco G, Serenari M, Renzulli M, Alemanni LV, Rossini B, Pettinari I, Dajti E, Ravaioli F, Golfieri R, Cescon M, Festi D, Colecchia A. Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments. J Gastroenterol 2020;55:927-43. [PMID: 32748172 DOI: 10.1007/s00535-020-01711-w] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Bednarsch J, Czigany Z, Heij LR, Liu D, den Dulk M, Wiltberger G, Bruners P, Ulmer TF, Neumann UP, Lang SA. Compelling Long-Term Results for Liver Resection in Early Cholangiocarcinoma. J Clin Med 2021;10:2959. [PMID: 34209368 DOI: 10.3390/jcm10132959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Marasco G, Trevisani F; Italian Liver Cancer (ITA.LI.CA.) group. Time to move beyond the classical prognostic systems for patients with advanced hepatocellular carcinoma undergoing Sorafenib. Dig Liver Dis 2021;53:1210-1. [PMID: 34052178 DOI: 10.1016/j.dld.2021.04.037] [Reference Citation Analysis]
3 Kukla M, Skladany L, Menżyk T, Derra A, Stygar D, Skonieczna M, Hudy D, Nabrdalik K, Gumprecht J, Marlicz W, Koulaouzidis A, Koller T. Irisin in Liver Cirrhosis. J Clin Med 2020;9:E3158. [PMID: 33003490 DOI: 10.3390/jcm9103158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Marasco G, Dajti E, Serenari M, Alemanni LV, Ravaioli F, Ravaioli M, Vestito A, Vara G, Festi D, Golfieri R, Cescon M, Renzulli M, Colecchia A. Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis. Cancers (Basel) 2022;14:1935. [PMID: 35454842 DOI: 10.3390/cancers14081935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lim J, Kim KW, Ko Y, Jang IY, Lee YS, Chung YH, Lee HC, Lim YS, Kim KM, Shim JH, Choi J, Lee D. The role of muscle depletion and visceral adiposity in HCC patients aged 65 and over undergoing TACE. BMC Cancer 2021;21:1164. [PMID: 34715813 DOI: 10.1186/s12885-021-08905-2] [Reference Citation Analysis]
6 Pu Z, Ren Z, Xu Q, Wang X, Chen J, Chen J. Editorial: The role of tumor microenvironment in primary liver cancer therapeutic resistance. Front Oncol 2022;12:938557. [DOI: 10.3389/fonc.2022.938557] [Reference Citation Analysis]
7 Hari A. Muscular abnormalities in liver cirrhosis. World J Gastroenterol 2021; 27(29): 4862-4878 [PMID: 34447231 DOI: 10.3748/wjg.v27.i29.4862] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Salman A, Salman M, Moustafa A, Shaaban HE, El-Mikkawy A, Labib S, Youssef A, Omar MG, Matter M, Elkassar H. Impact of Sarcopenia on Two-Year Mortality in Patients with HCV-Associated Hepatocellular Carcinoma After Radiofrequency Ablation. J Hepatocell Carcinoma 2021;8:313-20. [PMID: 33954153 DOI: 10.2147/JHC.S300680] [Reference Citation Analysis]
9 Zou X, Fan W, Xue M, Li J. Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression. Cancer Manag Res 2021;13:4013-29. [PMID: 34040442 DOI: 10.2147/CMAR.S304591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kovac JD, Ivanovic A, Milovanovic T, Micev M, Alessandrino F, Gore RM. An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation. Radiol Oncol 2021;55:130-43. [PMID: 33544992 DOI: 10.2478/raon-2021-0004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1611-44. [PMID: 34233031 DOI: 10.1002/hep.32049] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 39.0] [Reference Citation Analysis]
12 Kikuchi N, Uojima H, Hidaka H, Iwasaki S, Wada N, Kubota K, Nakazawa T, Shibuya A, Fujikawa T, Kako M, Sato T, Koizumi W. Prospective study for an independent predictor of prognosis in liver cirrhosis based on the new sarcopenia criteria produced by the Japan Society of Hepatology. Hepatol Res 2021;51:968-78. [PMID: 34269502 DOI: 10.1111/hepr.13698] [Reference Citation Analysis]
13 van Dijk AM, Coppens BJP, van Beers MA, Bruins Slot AS, Verstraete CJR, de Bruijne J, Vleggaar FP, van Erpecum KJ. Nutritional status in patients with hepatocellular carcinoma: Potential relevance for clinical outcome. Eur J Intern Med 2022:S0953-6205(22)00250-3. [PMID: 35902333 DOI: 10.1016/j.ejim.2022.07.002] [Reference Citation Analysis]
14 Xiong J, Wu Y, Hu H, Kang W, Li Y, Jin P, Shao X, Li W, Tian Y. Prognostic Significance of Preoperative Sarcopenia in Patients With Gastric Cancer Liver Metastases Receiving Hepatectomy. Front Nutr 2022;9:878791. [PMID: 35619951 DOI: 10.3389/fnut.2022.878791] [Reference Citation Analysis]
15 Federico P, Giunta EF, Pappalardo A, Tufo A, Marte G, Attademo L, Fabbrocini A, Petrillo A, Daniele B. How to Treat Hepatocellular Carcinoma in Elderly Patients. Pharmaceuticals (Basel) 2021;14:233. [PMID: 33800217 DOI: 10.3390/ph14030233] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Thormann M, Omari J, Pech M, Damm R, Croner R, Perrakis A, Strobel A, Wienke A, Surov A. Low skeletal muscle mass and post-operative complications after surgery for liver malignancies: a meta-analysis. Langenbecks Arch Surg 2022. [PMID: 35583832 DOI: 10.1007/s00423-022-02541-5] [Reference Citation Analysis]
17 Marasco G, Dajti E, Ravaioli F, Brocchi S, Rossini B, Alemanni LV, Peta G, Bartalena L, Golfieri R, Festi D, Colecchia A, Renzulli M. Clinical impact of sarcopenia assessment in patients with liver cirrhosis. Expert Rev Gastroenterol Hepatol 2021;15:377-88. [PMID: 33196344 DOI: 10.1080/17474124.2021.1848542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Badran H, Elsabaawy MM, Ragab A, Aly RA, Alsebaey A, Sabry A. Baseline Sarcopenia is Associated with Lack of Response to Therapy, Liver Decompensation and High Mortality in Hepatocellular Carcinoma Patients. Asian Pac J Cancer Prev 2020;21:3285-90. [PMID: 33247686 DOI: 10.31557/APJCP.2020.21.11.3285] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
19 Yang S, Zhang Z, Su T, Yu J, Cao S, Wang H, Jin L. CT-based skeletal muscle loss for predicting poor survival in patients with hepatocellular carcinoma experiencing curative hepatectomy plus adjuvant transarterial chemoembolization: a preliminary retrospective study. Eur J Med Res 2022;27. [DOI: 10.1186/s40001-022-00760-6] [Reference Citation Analysis]
20 Kornberg A, Kaschny L, Kornberg J, Friess H. Preoperative Prognostic Nutritional Index May Be a Strong Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation. JHC 2022;Volume 9:649-60. [DOI: 10.2147/jhc.s366107] [Reference Citation Analysis]
21 Li Q, Zhang L, Hou ZH, Zhao DX, Li JB, Zhang S, Yin Y, Ni CF, Chen T. High Visceral Adipose Tissue Density Correlates With Unfavorable Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Front Cell Dev Biol 2021;9:710104. [PMID: 34568324 DOI: 10.3389/fcell.2021.710104] [Reference Citation Analysis]
22 Hanai T, Hiraoka A, Shiraki M, Sugimoto R, Taniki N, Hiramatsu A, Nakamoto N, Iwasa M, Chayama K, Shimizu M. Utility of the SARC-F Questionnaire for Sarcopenia Screening in Patients with Chronic Liver Disease: A Multicenter Cross-Sectional Study in Japan. J Clin Med 2021;10:3448. [PMID: 34362231 DOI: 10.3390/jcm10153448] [Reference Citation Analysis]
23 Nakano O, Kawai H, Kobayashi T, Kohisa J, Ikarashi S, Hayashi K, Yokoyama J, Terai S. Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer. Cancer Med 2021;10:4291-301. [PMID: 33993635 DOI: 10.1002/cam4.3964] [Reference Citation Analysis]
24 Marasco G, Sadalla S, Vara G, Golfieri R, Festi D, Colecchia A, Renzulli M. Imaging Software-Based Sarcopenia Assessment in Gastroenterology: Evolution and Clinical Meaning. Can J Gastroenterol Hepatol. 2021;2021:6669480. [PMID: 33505942 DOI: 10.1155/2021/6669480] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
25 Perisetti A, Goyal H, Yendala R, Chandan S, Tharian B, Thandassery RB. Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions. World J Gastroenterol 2022; 28(4): 432-448 [DOI: 10.3748/wjg.v28.i4.432] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Zhao C, Shi Q, Li H, Cui X, Xi Y, Cao Y, Xiang Z, Li F, Sun J, Liu J, Li T, Wei W, Xiong B, Li Z. Shape Designed Implanted Drug Delivery System for In Situ Hepatocellular Carcinoma Therapy. ACS Nano 2022. [PMID: 35549172 DOI: 10.1021/acsnano.2c03768] [Reference Citation Analysis]
27 Bertuzzo VR, Renzulli M, Clemente A, Cucchetti A, Maroni L, Frascaroli G, Pellegrini S, Dajti E, Spinelli D, Peta G, Maria Ierardi A, Carrafiello G, Strigari L, Colecchia A, Golfieri R, Pinna AD, Ravaioli M, Cescon M. Pre-transplant Psoas Muscle Density as a Ready-to-Use and Low-cost Predictor of Patient Survival After Liver Transplant. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.99690] [Reference Citation Analysis]